Select Page
📈 Premarket Watchlist – February 24, 2026
Published on: February 23, 2026

 

1️⃣ $VIR (Vir Biotechnology Inc.) | 🧬 Biotech/Oncology

Current Status:

  • Price: $11.80 (+58.81%)
  • Float: 85.53M
  • After-Hours Volume: 9.32M (2,400%+ RVOL)
  • Key Times: After-hours high 4:44 PM ET, Support test 4:02 PM ET

Trading Levels:

  • After-Hours Range: $7.43–$12.00
  • Key Support: $9.57 (mid-AH consolidation), $10.65 (late AH breakout)
  • Entry Zones: → $11.00 / $11.60

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $12.00 | T2 $12.50 | T3 $13.25 | T4 $14.00 | T5 $15.00
  • Stop Loss: $10.45 (dynamic, max 5% risk)
  • Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #2 Momentum +28% RV 14x, #4 Breakout +54% RV 31x, #5 Breakout +59% RV 37x, #3 Momentum +41% RV 24x
  • Volume: 9.32M shares, $109.93M dollar volume (2,400%+ RVOL)
  • Indicators: RSI overbought, MACD strong bullish crossover, OBV surging, above VWAP, higher lows from $7.43, above 9 EMA/20 MA
  • Pattern: Parabolic breakout with stair-step higher lows through AH (5m)
  • Catalyst: Vir Biotechnology Reports Positive Updated Phase 1 Results for PRO-XTEN Dual-masked T-Cell Engager VIR-5500 in Metastatic Prostate Cancer; Astellas and Vir Announce Global Strategic Collaboration — Vir Biotechnology press release, 02/24/2026

2️⃣ $MYGN (Myriad Genetics Inc.) | 🧬 Biotech/Diagnostics

Current Status:

  • Price: $5.43 (+23.97%)
  • Float: 89M
  • After-Hours Volume: 1.16M (1,300%+ RVOL)
  • Key Times: After-hours high 3:15 PM ET, Support test 3:00 PM ET

Trading Levels:

  • After-Hours Range: $4.38–$5.43
  • Key Support: $5.15 (late AH consolidation), $5.00 (psychological)
  • Entry Zones: → $5.15 / $5.41

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $5.75 | T2 $6.00 | T3 $6.50 | T4 $7.00 | T5 $7.50
  • Stop Loss: $4.90 (dynamic, max 5% risk)
  • Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #1 +20% RV 3x, #2 Breakout +26% RV 13x
  • Volume: 1.16M shares, $6.30M dollar volume (1,300%+ RVOL)
  • Indicators: RSI elevated, MACD bullish crossover, OBV rising, above VWAP, higher lows from $4.38, above 9 EMA/20 MA
  • Pattern: Earnings gap-up with consolidation near highs (5m)
  • Catalyst: Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution — Myriad Genetics press release, 02/24/2026

3️⃣ $SGHC (Super Group Ltd.) | 🎰 Consumer/Online Gaming

Current Status:

  • Price: $11.32 (+16.48%)
  • Float: 153M
  • After-Hours Volume: 1.25M (900%+ RVOL)
  • Key Times: After-hours high 3:15 PM ET, Support test 3:00 PM ET

Trading Levels:

  • After-Hours Range: $9.72–$11.32
  • Key Support: $10.50 (mid-AH level), $11.03 (late AH breakout)
  • Entry Zones: → $11.00 / $11.30

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $11.75 | T2 $12.00 | T3 $12.50 | T4 $13.00 | T5 $14.00
  • Stop Loss: $10.45 (dynamic, max 5% risk)
  • Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #1 +6% RV 4x, #2 Breakout +15% RV 9x
  • Volume: 1.25M shares, $14.15M dollar volume (900%+ RVOL)
  • Indicators: RSI elevated, MACD bullish, OBV rising, above VWAP, higher lows from $9.72, above 9 EMA/20 MA
  • Pattern: Earnings breakout with consolidation near highs (5m)
  • Catalyst: Super Group Reports Financial Results for Fourth Quarter and Full Year 2025 — Super Group press release/Form 6-K, 02/24/2026

4️⃣ $MGRX (Mangoceuticals Inc.) | 🧬 Biotech/Avian Health

Current Status:

  • Price: $0.545 (+3.00%)
  • Float: 13M
  • After-Hours Volume: 6.20M (5,900%+ RVOL)
  • Key Times: After-hours high 3:00 PM ET, Support test 3:08 PM ET

Trading Levels:

  • After-Hours Range: $0.520–$0.545
  • Key Support: $0.520 (AH low), $0.530 (consolidation)
  • Entry Zones: → $0.530 / $0.545

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $0.580 | T2 $0.620 | T3 $0.660 | T4 $0.700 | T5 $0.750
  • Stop Loss: $0.500 (dynamic, max 5% risk)
  • Trailing Stop: 10% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #2 +3% RV 59x
  • Volume: 6.20M shares, $3.38M dollar volume (5,900%+ RVOL)
  • Indicators: RSI neutral, MACD resetting bullish, OBV elevated, watching VWAP reclaim, above 9 EMA
  • Pattern: Consolidation near highs with massive RVOL (1m/5m)
  • Catalyst: Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study — Mangoceuticals press release, 02/24/2026

5️⃣ $SILO (Silo Pharma Inc.) | 🧬 Biotech/Psychedelics

Current Status:

  • Price: $0.390 (+38.69%)
  • Float: 13M
  • After-Hours Volume: 14.55M (2,200%+ RVOL)
  • Key Times: After-hours high 3:27 PM ET, Support test 3:00 PM ET

Trading Levels:

  • After-Hours Range: $0.280–$0.424
  • Key Support: $0.359 (mid-AH consolidation), $0.375 (late AH level)
  • Entry Zones: → $0.375 / $0.390

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $0.424 | T2 $0.450 | T3 $0.500 | T4 $0.550 | T5 $0.600
  • Stop Loss: $0.350 (dynamic, max 5% risk)
  • Trailing Stop: 12% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #3 Momentum +31% RV 22x, #4 Momentum +48% RV 36x, #2 Momentum +25% RV 16x, 0 Borrow CTB 6.52%
  • Volume: 14.55M shares, $5.67M dollar volume (2,200%+ RVOL)
  • Indicators: RSI elevated, MACD bullish, OBV surging, above VWAP, higher lows from $0.280, above 9 EMA/20 MA
  • Pattern: Momentum breakout with stair-step higher through AH (5m)
  • Catalyst: Silo Pharma Announces Share Buyback Program — Silo Pharma press release, 02/24/2026

6️⃣ $GIPR (Generation Income Properties Inc.) | 🏗️ Real Estate/REIT

Current Status:

  • Price: $0.670 (+24.07%)
  • Float: 4.6M
  • After-Hours Volume: 5.95M (2,400%+ RVOL)
  • Key Times: After-hours high 3:48 PM ET, Support test 3:00 PM ET

Trading Levels:

  • After-Hours Range: $0.540–$0.819
  • Key Support: $0.590 (early AH level), $0.680 (mid-AH breakout)
  • Entry Zones: → $0.670 / $0.700

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $0.766 | T2 $0.819 | T3 $0.900 | T4 $1.00 | T5 $1.15
  • Stop Loss: $0.620 (dynamic, max 5% risk)
  • Trailing Stop: 10% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #1 +3% RV 0.54x, #2 Breakout +18% RV 3x, #3 REV +23% RV 7x, #4 Breakout +43% RV 24x
  • Volume: 5.95M shares, $3.99M dollar volume (2,400%+ RVOL)
  • Indicators: RSI elevated, MACD bullish, OBV surging, above VWAP, higher lows from $0.540, above 9 EMA/20 MA
  • Pattern: Multi-hit breakout with wide range and consolidation near highs (5m)
  • Catalyst: SEC Form 8-K/A and Form 8-K filings — SEC/EDGAR, 02/24/2026

7️⃣ $GNPX (Genprex Inc.) | 🧬 Biotech/Gene Therapy

Current Status:

  • Price: $2.55 (+43.00%)
  • Float: 2.2M
  • After-Hours Volume: 1.70M (1,200%+ RVOL)
  • Key Times: After-hours high 6:13 PM ET, Support test 5:14 PM ET

Trading Levels:

  • After-Hours Range: $1.78–$2.55
  • Key Support: $2.20 (mid-AH consolidation), $2.40 (late AH level)
  • Entry Zones: → $2.40 / $2.55

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $2.75 | T2 $3.00 | T3 $3.25 | T4 $3.50 | T5 $4.00
  • Stop Loss: $2.25 (dynamic, max 5% risk)
  • Trailing Stop: 10% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #4 Breakout +43% RV 12x, Known Runner
  • Volume: 1.70M shares, $4.34M dollar volume (1,200%+ RVOL)
  • Indicators: RSI overbought, MACD strong bullish, OBV surging, above VWAP, higher lows from $1.78, above 9 EMA/20 MA
  • Pattern: Low float breakout with Known Runner tag and consolidation near highs (5m)
  • Catalyst: Genprex Strengthens In… (strategic update) — Genprex press release/Form 8-K, 02/24/2026

8️⃣ $KYNB (Kyntra Bio Inc.) | 🧬 Biotech/Oncology

Current Status:

  • Price: $9.23 (+11.00%)
  • Float: 3.8M
  • After-Hours Volume: 1.00M (200%+ RVOL)
  • Key Times: After-hours high 4:10 PM ET, Support test 4:00 PM ET

Trading Levels:

  • After-Hours Range: $8.31–$9.23
  • Key Support: $8.50 (early AH level), $9.00 (psychological)
  • Entry Zones: → $9.00 / $9.23

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $9.75 | T2 $10.00 | T3 $10.50 | T4 $11.00 | T5 $12.00
  • Stop Loss: $8.55 (dynamic, max 5% risk)
  • Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #1 +11% RV 2x
  • Volume: 1.00M shares, $9.23M dollar volume (200%+ RVOL)
  • Indicators: RSI elevated, MACD bullish, OBV rising, above VWAP, above 9 EMA/20 MA
  • Pattern: Gap-up with consolidation near highs (5m)
  • Catalyst: Kyntra Bio Announces Positive Data from Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026 — Kyntra Bio press release, 02/24/2026

9️⃣ $TARA (Protara Therapeutics Inc.) | 🧬 Biotech/Oncology

Current Status:

  • Price: $7.50 (+10.00%)
  • Float: 47M
  • After-Hours Volume: 5.00M (200%+ RVOL)
  • Key Times: After-hours high 4:02 PM ET, Support test 4:00 PM ET

Trading Levels:

  • After-Hours Range: $6.82–$7.50
  • Key Support: $7.00 (psychological), $7.25 (mid-AH level)
  • Entry Zones: → $7.25 / $7.50

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $7.85 | T2 $8.00 | T3 $8.50 | T4 $9.00 | T5 $10.00
  • Stop Loss: $6.90 (dynamic, max 5% risk)
  • Trailing Stop: 8% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #1 +10% RV 2x
  • Volume: 5.00M shares, $37.50M dollar volume (200%+ RVOL)
  • Indicators: RSI elevated, MACD bullish, OBV rising, above VWAP, above 9 EMA/20 MA
  • Pattern: Gap-up with consolidation near highs (5m)
  • Catalyst: TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer — Protara Therapeutics press release, 02/24/2026

🔟 $BOXL (Boxlight Corporation) | 🤖 Technology/EdTech

Current Status:

  • Price: $1.64 (+11.56%)
  • Float: 930K
  • After-Hours Volume: 1.97M (800%+ RVOL)
  • Key Times: After-hours high 3:38 PM ET, Support test 3:27 PM ET

Trading Levels:

  • After-Hours Range: $1.47–$1.70
  • Key Support: $1.55 (early AH level), $1.60 (late AH consolidation)
  • Entry Zones: → $1.60 / $1.64

Entry Confirmation:

  • Require 2+ consecutive 1m/5m closes above entry zone with reversal or volume surge.
  • Do NOT enter on first touch without confirmation.
  • Targets: T1 $1.75 | T2 $1.85 | T3 $2.00 | T4 $2.20 | T5 $2.50
  • Stop Loss: $1.50 (dynamic, max 5% risk)
  • Trailing Stop: 10% (scaled to volatility)

Technical Confirmation:

  • Scanner Hits: TrendVision #1 +16% RV 4x, #2 Momentum +16% RV 8x, R/S 1:6 2 months ago, Potential Squeeze
  • Volume: 1.97M shares, $3.23M dollar volume (800%+ RVOL)
  • Indicators: RSI elevated, MACD bullish, OBV rising, above VWAP, higher lows from $1.47, above 9 EMA/20 MA
  • Pattern: Ultra-low float potential squeeze with R/S history and consolidation near highs (5m)
  • Catalyst: SEC Form 8-K filing; Potential Squeeze with 930K ultra-low float and R/S 1:6 two months ago — SEC/EDGAR/TrendVision scanner, 02/24/2026
Biotech/Avian Health | Biotech/Diagnostics | Biotech/Gene Therapy | Biotech/Oncology | Biotech/Psychedelics | Consumer/Online Gaming | Premarket Watch List | Real Estate/REIT | Technology/EdTech
$BOXL | $GIPR | $GNPX | $KYNB | $MGRX | $MYGN | $SGHC | $SILO | $TARA | $VIR
Category

Join Sowell Trading Group Today!

Unlock the full potential of your trading journey with Sowell Trading. Become a part of our vibrant community and gain access to live trading alerts, expert technical analysis, and the latest market news. Don’t miss out on the opportunity to elevate your trading skills and achieve your financial goals. Click below to start your journey with us!

Get Started Now